Monday, November 20, 2017 8:07:15 AM
"Invitation to Xenoholographic Augmented Reality Product Launch WebCast hosted by Tim Huckaby on November 28th at 11:00 am EST
On November 28th, 2017 at 11:00 am EST, Mr. Tim Huckaby will be presenting the XenoHolographic Product Launch & Roadmap. Mr. Huckaby, Chief Strategy Officer of XenoHolographic, will also participate in a Q&A at the end of the formal presentation. This event will be limited to 100 participants but also will be recorded and available online the next day at www.imaginationpark.com.
XenoRoom and XenoSidekick will, when launched, reduce the friction for consumers and companies as they deliver interactive holographic experiences to their users. XenoRoom is a location-based holographic experience engine allowing businesses to upload 3D content to the cloud and automatically download and render it. XenoSidekick is a toolkit developed to allow for seamless interaction with holograms irrespective of the augmented reality headset brand. XenoApp will also be discussed in this presentation.
For more information about XenoHolographic, please visit the company website at www. xenoholographic.com
Xenoholographic Product Launch hosted by Tim Huckaby
Tue, Nov 28, 2017 11am EST
Please join my meeting from your computer, tablet or smartphone.
https://global.gotomeeting.com/join/444897477
You can also dial in using your phone.
United States: +1 (571) 317-3129
Access Code: 444-897-477
More phone numbers
Canada: +1 (647) 497-9350
About XENOHolographic Inc.
XENOHolographic Inc. is a Delaware corporation focused on delivering products, services, and content enabling holographic experiences within augmented and mixed reality. This company is a joint venture formed by Imagination Park Entertainment Inc. and InterKnowlogy, LCC. Contact the company at Info@xenoholographic.com.
About Imagination Park
Imagination Park is an emerging digital content production company, working with talented filmmakers around the world to bring conventional as well as virtual reality content to life.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM